ERBB2 and cancer: We confirmed these results both experimentally by reconstituting KLK5 expression in cell lines [37], and clinically by showing a correlation between KLK5 expression and a number of these miRNAs in high metastatic potential cancers such as luminal B and Her-2 enriched subtypes.